A detailed history of Aqr Capital Management LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 14,504 shares of STTK stock, worth $16,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,504
Holding current value
$16,099
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $4.85 $43,512 - $70,344
14,504 New
14,504 $50,000
Q2 2022

Aug 15, 2022

SELL
$2.7 - $4.59 $11,620 - $19,755
-4,304 Reduced 10.57%
36,426 $148,000
Q1 2022

May 16, 2022

BUY
$4.22 - $8.89 $171,880 - $362,089
40,730 New
40,730 $174,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $47M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.